These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31955391)

  • 1. Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.
    Meca-Lallana J; Maurino J; Hernández-Pérez MÁ; Sempere ÁP; Brieva L; García-Arcelay E; Terzaghi M; Saposnik G; Ballesteros J
    Neurol Ther; 2020 Jun; 9(1):173-179. PubMed ID: 31955391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5).
    Meca-Lallana V; Brañas-Pampillón M; Higueras Y; Candeliere-Merlicco A; Aladro-Benito Y; Rodríguez-De la Fuente O; Salas-Alonso E; Maurino J; Ballesteros J
    Mult Scler J Exp Transl Clin; 2019; 5(4):2055217319887987. PubMed ID: 31741743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
    Meca-Lallana JE; Maurino J; Pérez-Miralles F; Forero L; Sepúlveda M; Calles C; Martínez-Ginés ML; González-Suárez I; Boyero S; Romero-Pinel L; Sempere ÁP; Meca-Lallana V; Querol L; Costa-Frossard L; Prefasi D; Gómez-Ballesteros R; Ballesteros J
    PLoS One; 2021; 16(7):e0255317. PubMed ID: 34324586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis.
    Ballesteros J; Moral E; Brieva L; Ruiz-Beato E; Prefasi D; Maurino J
    Health Qual Life Outcomes; 2017 Apr; 15(1):79. PubMed ID: 28431587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring burden in caregivers of people with multiple sclerosis: psychometric properties of the CSI questionnaire.
    García-Domínguez JM; Martínez-Ginés ML; Carmona O; Caminero AB; Prefasi D; Maurino J; Ballesteros J;
    Patient Prefer Adherence; 2019; 13():101-106. PubMed ID: 30666093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Stigma in Multiple Sclerosis: Psychometric Properties of the Eight-Item Stigma Scale for Chronic Illness (SSCI-8).
    Ballesteros J; Martínez-Ginés ML; García-Domínguez JM; Forero L; Prefasi D; Maurino J;
    Int J MS Care; 2019; 21(5):195-199. PubMed ID: 31680780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unidimensional 12-item Zarit Caregiver Burden Interview for the assessment of dementia caregivers' burden obtained by item response theory.
    Ballesteros J; Santos B; González-Fraile E; Muñoz-Hermoso P; Domínguez-Panchón AI; Martín-Carrasco M
    Value Health; 2012 Dec; 15(8):1141-7. PubMed ID: 23244818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring productivity loss in early relapsing-remitting multiple sclerosis.
    Sainz de la Maza S; Maurino J; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Campo-Amigo MD; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; de Alda LR; Gómez-Ballesteros R; Castillo-Triviño T
    Mult Scler Relat Disord; 2022 Feb; 58():103398. PubMed ID: 35216781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.
    Fitzgerald KC; Salter A; Tyry T; Fox RJ; Cutter G; Mowry EM; Marrie RA
    Mult Scler Relat Disord; 2019 Apr; 29():86-93. PubMed ID: 30690340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23).
    Martínez-Ginés ML; García-Domínguez JM; Forero L; Canal N; Rebollo P; Prefasi D; Honan CA; Maurino J
    Mult Scler Relat Disord; 2018 May; 22():115-119. PubMed ID: 29656271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
    Green R; Kalina J; Ford R; Pandey K; Kister I
    Appl Neuropsychol Adult; 2017; 24(2):183-189. PubMed ID: 27077687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?
    Saposnik G; Sotoca J; Sempere ÁP; Candeliere-Merlicco A; Díaz-Abós P; Tobler PN; Terzaghi M; Maurino J
    Mult Scler Relat Disord; 2020 Oct; 45():102354. PubMed ID: 32629401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which symptoms contribute the most to patients' perception of health in multiple sclerosis?
    Green R; Cutter G; Friendly M; Kister I
    Mult Scler J Exp Transl Clin; 2017; 3(3):2055217317728301. PubMed ID: 28904811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
    Wicks P; Vaughan TE; Massagli MP
    Health Qual Life Outcomes; 2012 Jun; 10():70. PubMed ID: 22709981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-cultural adaptation, reliability, and validity of the Turkish version of the SymptoMScreen.
    Özkeskin M; Özden F; Bakırhan S; Yüceyar N
    Mult Scler Relat Disord; 2021 May; 50():102803. PubMed ID: 33561665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity and reliability of the multidimensional assessment of fatigue scale in Iranian patients with relapsing-remitting subtype of multiple sclerosis.
    Behrangrad S; Kordi Yoosefinejad A
    Disabil Rehabil; 2018 Mar; 40(6):673-677. PubMed ID: 28325094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian adaptation and psychometric validation of the Fatigue Impact Scale (FIS) and its modified versions in adults with multiple sclerosis: a Rasch analysis study.
    Piscitelli D; Brichetto G; Geri T; Battista S; Testa M; Monti Bragadin M; Pellicciari L
    Disabil Rehabil; 2024 Jan; ():1-14. PubMed ID: 38236054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.
    Castillo-Triviño T; Gómez-Ballesteros R; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco-Quílez MR; García-Soto JD; Del Campo-Amigo M; Navarro-Cantó L; Agüera E; Garcés-Redondo M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; Mauriño J; Sainz de la Maza S
    Mult Scler Relat Disord; 2022 Aug; 64():103969. PubMed ID: 35728432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the fatigue severity scale in Croatian population of patients with multiple sclerosis disease: Factor structure, internal consistency, and correlates.
    Jerković A; Proroković A; Matijaca M; Katić AĆ; Košta V; Mihalj M; Dolić K; Đogaš Z; Vidaković MR
    Mult Scler Relat Disord; 2022 Feb; 58():103397. PubMed ID: 35216780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.